The Framingham score, used to evaluate risk for a cardiovascular event, is low-balling the threat in patients with HIV. And conflicting results on the success of statins is perplexing specialists.
Medscape Medical News
This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.